Wai Yuen Tong Medicine Holdings Limited provided consolidated earnings guidance for the six months ended 30 September 2023. The group is expected to record a turnaround from a loss attributable to owners of the parent for the six months ended 30 September 2022 of approximately HKD 53.4 million to a profit attributable to owners of the parent of not more than approximately HKD 20.0 million for the six months ended 30 September 2023.